Stocks Comparison
Baxter International vs Solventum: revenue, profit, margins and growth compared
Baxter International brought in $11.2B of revenue in fiscal 2025, Solventum $8.3B in fiscal 2025. Revenue changed by +5.7% at Baxter International and +0.9% at Solventum on the year before, so Baxter International grew faster. Baxter International kept -8.5% of its revenue as net profit, Solventum 18.7%. Free cash flow was $332M at Baxter International and -$10M at Solventum.
Side by side, latest fiscal year
| BAX | SOLV | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $11.2B | $8.3B |
| Revenue growth | +5.7% | +0.9% |
| Net income | -$957M | $1.6B |
| Net margin | -8.5% | 18.7% |
| Free cash flow | $332M | -$10M |
| Free cash flow margin | 3.0% | -0.1% |
| Earnings per share (diluted) | -$1.87 | $8.88 |
| Cash | $2B | $878M |
| Debt | $9.4B | $5B |
| Price to earnings | n/a | 10.1 |
| Market value | $12.1B | $15.2B |
| Dividend yield | 2.23% | n/a |
| Rank by revenue in sector | #42 of 523 · Health care | #49 of 523 · Health care |
Over the years
Questions about Baxter International and Solventum
Which is bigger by revenue, Baxter International or Solventum?
Baxter International is bigger by revenue: $11.2B in fiscal 2025, against $8.3B for Solventum in fiscal 2025.
Which keeps more of its revenue as profit, Baxter International or Solventum?
Baxter International had a net margin of -8.5% in fiscal 2025; Solventum had 18.7% in fiscal 2025.
Which grew revenue faster, Baxter International or Solventum?
In their latest fiscal years revenue changed by +5.7% at Baxter International and +0.9% at Solventum.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.